This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Empirical therapy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Initial empirical therapy includes(1):

  • urgent transfer to hospital
  • in general practice, if bacterial meningitis is suspected a single STAT dose of benzylpenicillin should be given before urgent transfer to the hospital
  • dexamethasone may be indicated as an adjunct in adults, before or when antibiotics are started.

Alternative therapies that may be used as empirical therapy based on the likely agent for the age of the patient are:

  • infants younger than three months:
    • cefotaxime, and ampicillin because of the possibility of Listeria meningitis
  • children:
    • ceftriaxone or cefotaxime
    • second line is chloramphenicol and ampicillin
  • adults:
    • ceftriaxone or cefotaxime
    • second line therapies: benzylpenicillin or ampicillin
  • older adults:
    • cefotaxime or ceftriaxone and ampicillin

Note: STAT indicates that intervention is emergent

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.